Hi, How Are You?
Forgot Password?
Sign Up
kalbe_med_lg_white
ID
  • Home
  • Article
  • Events
    All Events Webinar new!
  • Product & Disease
    Product Disease Pharmacovigilance Medical Calculator new!
  • Education
    CPD/CME CDK Multimedia new!
  • Partnership
    HR Customer Partnership new!
  • FAQ & Feedback
  • Login
  • Register
Articles
no_image no_image no_image no_image no_image
Topics
All | Vitamin & Nutrition | COVID-19 | Cardiology | Cancer | Drug
Vaccinology
Radiology
Obstetry and Gynecology
Family Medicine
Anesthesiology
Epidemiology
COVID-19
Cancer
Cardiology
Pediatric
Clinical Procedure
Common Diseases
Dental And Oral Health
Dermathology And Aesthetic
Drug
Endocrinology
Eyes
Female
Gastroenterology
General Information
Geriatry
Hematology
Hepatology
Allergy & Immunology
Infection Disease
Inflammation
Male
Mental Health
Mouth Ear Nose
Nephrology
Neurology
Pain
Pathology
Pulmonology
Skeletal & Muscle
Surgery & Recovery
Urology
Vitamin & Nutrition
SPECIAL COVERAGE Cancer
featured_img
Kalbe Dapatkan Izin Edar Obat Rituxikal, Produk Biologi Antibodi Monoklonal Pertama di Indonesia
by dr. Dita Arccinirmala | 31 Januari 2023
Jakarta, 30 Januari 2023 – PT Kalbe Farma Tbk (Kalbe) melalui anak usaha PT Kalbio Global Medika mendukung pemerintah terkait produksi produk farmasi lokal dengan meluncurkan produk Rituximab dengan nama dagang Rituxikal. Produk biologi antibodi monoklonal ini pertama yang berhasil diproduksi di Indonesia dan telah memiliki izin edar lokal oleh Badan Pengawas Obat dan Makanan (BPOM) RI.
Tamoxifen Dosis Rendah untuk Mencegah Kanker Payudara Invasif
by dr. Hastarita Lawrenti | 27 Desember 2022
cf3510af814aed12ccad5d5feaa23a32.jpg
Update Rekomendasi Penggunaan PARPi pada Pasien Kanker Ovarium
by dr. Hastarita Lawrenti | 10 Oktober 2022
f4225d31528e747065659197a0b5e9d3.jpg
Latest Articles
    Subscribe Status
    Home
    Article
    Products
    CPD/CME